Sanofi SA banner

Sanofi SA
BMV:SNYN

Watchlist Manager
Sanofi SA Logo
Sanofi SA
BMV:SNYN
Watchlist
Price: 755.29 MXN -0.09%
Market Cap: Mex$1.9T

Wall St Price Targets

SNYN Price Targets Summary
Sanofi SA

Wall Street analysts forecast SNYN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNYN is 980.3 MXN with a low forecast of 580.5 MXN and a high forecast of 1 185.81 MXN.

Lowest Forecast
Price Target
580.5 MXN
23% Downside
Average Forecast
Price Target
980.3 MXN
30% Upside
Highest Forecast
Price Target
1 185.81 MXN
57% Upside
Sanofi SA Competitors:
Price Targets
FCNCA
First Citizens BancShares Inc (Delaware)
9% Upside
OBT
Orange County Bancorp Inc
7% Upside

Revenue
Forecast

2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
5% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.

Gross Profit
Forecast

2% / Year
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
7% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 7%.

Operating Income
Forecast

2% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
14% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 14%.

Pre-Tax Income
Forecast

1% / Year
Past Growth
34% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
1% / Year
Past Growth
34% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 34%.

Net Income
Forecast

4% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
4% / Year
Past Growth
16% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 16%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SNYN's stock price target?
Price Target
980.3 MXN

According to Wall Street analysts, the average 1-year price target for SNYN is 980.3 MXN with a low forecast of 580.5 MXN and a high forecast of 1 185.81 MXN.

What is the Revenue forecast for Sanofi SA?
Projected CAGR
5%

Over the last 13 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 3 years is 5%.

What is the Gross Profit forecast for Sanofi SA?
Projected CAGR
7%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 7%.

What is the Operating Income forecast for Sanofi SA?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 3 years is 14%.

What is the Pre-Tax Income forecast for Sanofi SA?
Projected CAGR
34%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 34%.

What is the Net Income forecast for Sanofi SA?
Projected CAGR
16%

Over the last 13 years, the compound annual growth rate for Net Income has been 4%. The projected CAGR for the next 3 years is 16%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett